ClinicalTrials.Veeva

Menu

Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone. (PE)

S

Sohag University

Status and phase

Unknown
Phase 3

Conditions

Premature Ejaculation

Treatments

Drug: Dapoxietine and Combined Lidocaine 5% Spray
Drug: Tadalafil and Combined Dapoxietine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Therefore, this study will aim to assess the effectiveness and tolerability of the on-demand use of combined dapoxetine with tadalafil and combined dapoxetine with lidocaine 5% spray in treatment of patients with lifelong premature ejaculation and non-responding to dapoxetine alone.

Full description

This study will be carried out on 60 patients with lifelong premature ejaculation and non-responding to dapoxetine alone.

All patients will be equally divided into 2 groups (30 patients each). Group 1 was given on-demand 30 mg dapoxetine and 10 mg tadalafil 1 h before intercourse. Group 1 was given on-demand 30 mg dapoxetine 1 h before intercourse and apply lidocaine 5% spray on the glans penis 10 minutes the wash before intercourse.

Enrollment

60 estimated patients

Sex

Male

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • lifelong premature ejaculation and non-responding to dapoxetine alone.

Exclusion criteria

  • diabetes mellitus,
  • chronic prostatitis,
  • Advanced renal or hepatic diseases
  • neurological diseases
  • C.N.S. medications

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Patients with lifelong premature ejaculation and non-responding to dapoxetine alone
Active Comparator group
Description:
Group 1 was given on-demand 30 mg dapoxetine and 10 mg tadalafil 1 h before intercourse.
Treatment:
Drug: Tadalafil and Combined Dapoxietine
Patients with Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone.
Active Comparator group
Description:
Group 2 was given on-demand 30 mg dapoxetine 1 h before intercourse and apply lidocaine 5% spray on the glans penis 10 minutes the wash before intercourse.
Treatment:
Drug: Dapoxietine and Combined Lidocaine 5% Spray

Trial contacts and locations

1

Loading...

Central trial contact

Mohammed A Abu El-Hamd, MD; Mohammed Abu El-Hamd, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems